--- title: "R Todd Frederick, M.D. | Sutter Health" url: "https://www.sutterhealth.org/research/investigators/r-todd-frederick-md-1049681184" --- 1. [Home](https://www.sutterhealth.org/) / 2. [Research](https://www.sutterhealth.org/research) / 3. [Investigators](https://www.sutterhealth.org/research/investigators) / 4. R Todd Frederick, M.D. ![R Todd Frederick, M.D.](https://dyn.mktgcdn.com/p/DYa8wdK5N75wVC66dzWg4-1m5SyalXxULZ9bQLcc80o/fit=crop,gravity=auto,dpr=2,width=240,height=240) # R Todd Frederick, M.D. Investigator [View profile](https://www.sutterhealth.org/find-provider/dr-richard-t-frederick-1046241199) Dr. Frederick is a transplant hepatologist with CPMC’s Liver Disease Management and Transplant Program, and he serves as Director of Clinical Protocols and Liver Support Services. He investigates the pathophysiology and treatment of portal hypertension, hepatic encephalopathy, and liver support devices for acute and acute-on-chronic liver failure. Author of numerous manuscripts, book chapters, and abstracts, Dr. Frederick leads clinical trials of treatments for hepatic encephalopathy, hepatitis B and C, liver failure, and the management of liver transplantation. 2340 Clay Street Floor 3 San Francisco, CA 94115 ## Clinical trials - Clinical trial ### [Hepatitis LCAH3141 RE-AHFIRM](https://www.sutterhealth.org/research/clinical-trials/hepatitis-lcah3141-re-ahfirm-2075020771) RE-AHFIRM (RandomizEd Study of Larsucosterol in Alcohol-associated Hepatitis to Confirm saFety and effIcacy of tReatMent) **Status:** Open to Enrollment ```json {"@context":"https://schema.org","@type":"MedicalOrganization","name":"Sutter Health","@id":"https://www.sutterhealth.org/#medicalorganization","url":"https://www.sutterhealth.org","logo":"https://www.sutterhealth.org/static/images/sutter-health-logo.svg","address":{"@type":"PostalAddress","streetAddress":"2200 River Plaza Drive","addressLocality":"Sacramento","addressRegion":"CA","postalCode":"95833","addressCountry":"US"},"areaServed":{"@type":"AdministrativeArea","name":"California"},"sameAs":["https://www.facebook.com/SutterHealth","https://www.instagram.com/sutterhealth/","https://x.com/SutterHealth","https://www.youtube.com/sutterhealth","https://www.linkedin.com/company/sutter-health","https://en.wikipedia.org/wiki/Sutter_Health"]} ``` ```json {"@context":"https://schema.org","@type":"BreadcrumbList","@id":"https://www.sutterhealth.org/research/investigators/r-todd-frederick-md-1049681184#breadcrumblist","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https://www.sutterhealth.org/"},{"@type":"ListItem","position":2,"name":"Research","item":"https://www.sutterhealth.org/research"},{"@type":"ListItem","position":3,"name":"Investigators","item":"https://www.sutterhealth.org/research/investigators"},{"@type":"ListItem","position":4,"name":"R Todd Frederick, M.D."}]} ``` ```json {"@context":"https://schema.org","@type":"ProfilePage","@id":"https://www.sutterhealth.org/research/investigators/r-todd-frederick-md-1049681184#profilepage","url":"https://www.sutterhealth.org/research/investigators/r-todd-frederick-md-1049681184","name":"R Todd Frederick, M.D.","dateModified":"2026-06-09","breadcrumb":{"@id":"https://www.sutterhealth.org/research/investigators/r-todd-frederick-md-1049681184#breadcrumblist"},"primaryImageOfPage":{"@type":"ImageObject","contentUrl":"https://a.mktgcdn.com/p/DYa8wdK5N75wVC66dzWg4-1m5SyalXxULZ9bQLcc80o/200x200.webp","width":200,"height":200},"mainEntity":{"@id":"https://www.sutterhealth.org/research/investigators/r-todd-frederick-md-1049681184"}} ``` ```json {"@context":"https://schema.org","@type":"Person","@id":"https://www.sutterhealth.org/research/investigators/r-todd-frederick-md-1049681184","name":"R Todd Frederick, M.D.","givenName":"R","additionalName":"Todd","familyName":"Frederick","honorificSuffix":"M.D.","description":"Dr. Frederick is a transplant hepatologist with CPMC’s Liver Disease Management and Transplant Program, and he serves as Director of Clinical Protocols and Liver Support Services. He investigates the pathophysiology and treatment of portal hypertension, hepatic encephalopathy, and liver support devices for acute and acute-on-chronic liver failure. Author of numerous manuscripts, book chapters, and abstracts, Dr. Frederick leads clinical trials of treatments for hepatic encephalopathy, hepatitis B and C, liver failure, and the management of liver transplantation.","image":{"@type":"ImageObject","contentUrl":"https://a.mktgcdn.com/p/DYa8wdK5N75wVC66dzWg4-1m5SyalXxULZ9bQLcc80o/200x200.webp","representativeOfPage":true},"address":{"@type":"PostalAddress","streetAddress":"2340 Clay Street Floor 3","addressLocality":"San Francisco","addressRegion":"CA","postalCode":"94115","addressCountry":"US"},"affiliation":{"@id":"https://www.sutterhealth.org/#medicalorganization"},"mainEntityOfPage":{"@id":"https://www.sutterhealth.org/research/investigators/r-todd-frederick-md-1049681184#profilepage"},"sameAs":"https://www.sutterhealth.org/find-provider/dr-richard-t-frederick-1046241199"} ```